US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

18.32

-0.3352-1.80%

Post-market: 18.330.0052+0.03%16:05 EDT

Volume:59.75K

Turnover:1.09M

Market Cap:12.83M

PE:- -

High:18.55

Open:18.44

Low:18.14

Close:18.66

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Virtus LifeSci Biotech Clinical Trials ETF

Exchange:

NASDAQ

Establishment Date:

2014

Employees:

- -

Office Location:

One Financial Plaza,Hartford,Connecticut,United States

Website:

- -

Zip Code:

06103

Phone:

Fax:

(860) 241-1024

Introduction:

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BBC/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":18.3248,"timestamp":1745611200000,"preClose":18.66,"halted":0,"volume":59752,"hourTrading":{"tag":"盘后","latestPrice":18.33,"preClose":18.3248,"latestTime":"16:05 EDT","volume":2,"amount":36.6496,"timestamp":1745611512479},"delay":0,"floatShares":700004,"shares":700004,"eps":0,"marketStatus":"Market Closed","change":-0.3352,"latestTime":"04-25 16:00:00 EDT","open":18.44,"high":18.55,"low":18.14,"amount":1093791.925102,"amplitude":0.021972,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":18.66,"sharesOutstanding":800004,"nav":18.342,"aum":14673311.45,"dividendRate":0.013042,"bidAskSpread":0.002667,"preHourTrading":{"tag":"盘前","latestPrice":18.4522,"preClose":18.66,"latestTime":"08:00 EDT","volume":1000,"amount":18452.2,"timestamp":1745582404360},"postHourTrading":{"tag":"盘后","latestPrice":18.33,"preClose":18.3248,"latestTime":"16:05 EDT","volume":2,"amount":36.6496,"timestamp":1745611512479},"volumeRatio":0.3955551020379587,"impliedVol":0.3705,"impliedVolPercentile":0.94},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":700004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3955551020379587,"shares":700004,"dividePrice":0.239,"high":18.55,"amplitude":0.021972,"preClose":18.66,"low":18.14,"week52Low":13.42,"pbRate":"0.29","week52High":31.65,"institutionHeld":0,"latestPrice":18.3248,"eps":0,"divideRate":0.013042,"volume":59752,"delay":0,"ttmEps":0,"open":18.44,"prevYearClose":23.9429,"prevWeekClose":16.64,"prevMonthClose":17.54,"prevQuarterClose":17.54,"fiveDayClose":16.64,"twentyDayClose":19.07,"sixtyDayClose":22.9361},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":274653436,"yearFounded":2014,"address":"One Financial Plaza,Hartford,Connecticut,United States","zipCode":"06103","officePhone":"(800) 248-7971","officeFax":"(860) 241-1024"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0.1012},{"period":"1month","weight":-0.0216},{"period":"3month","weight":-0.2022},{"period":"6month","weight":-0.3719},{"period":"1year","weight":-0.2581},{"period":"ytd","weight":-0.2346}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (\"lead drug\") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":-0.011478},{"month":2,"riseRate":0.545455,"avgChangeRate":0.00808},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.021227},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.015924},{"month":5,"riseRate":0.6,"avgChangeRate":0.030917},{"month":6,"riseRate":0.6,"avgChangeRate":0.019045},{"month":7,"riseRate":0.5,"avgChangeRate":0.01202},{"month":8,"riseRate":0.6,"avgChangeRate":0.008824},{"month":9,"riseRate":0.3,"avgChangeRate":-0.029127},{"month":10,"riseRate":0.4,"avgChangeRate":-0.037661},{"month":11,"riseRate":0.7,"avgChangeRate":0.06824},{"month":12,"riseRate":0.4,"avgChangeRate":-0.001476}],"exchange":"NASDAQ","name":"Virtus LifeSci Biotech Clinical Trials ETF","nameEN":"Virtus LifeSci Biotech Clinical Trials ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-29","value":0.14733,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{}}}